How is Wolff-Parkinson-White (WPW) syndrome treated in patients who do not undergo RF ablation?

Updated: Jan 08, 2017
  • Author: Christopher R Ellis, MD, FACC, FHRS; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print

Long-term oral medication is the mainstay of therapy in patients not undergoing RF ablation. Response to long-term antiarrhythmic therapy for the prevention of further episodes of tachycardia in patients with WPW syndrome remains quite variable and unpredictable. Some drugs may paradoxically make the reciprocating tachycardia more frequent.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!